End-to-end regulatory services with strategic expertise for efficient lifecycle and data management operations and faster go-to-market.
Wipro partners with several life sciences companies and provides strategic consulting and solutions to small, medium and large pharma or biopharma companies. A key area of partnership is regulatory affairs. Wipro’s expertise and seasoned regulatory professionals bring strategic dimension in the regulatory operations delivery starting from drug development strategy, risk management, clinical affairs, medical affairs and post market surveillance.
With a qualitative and quantitative approach, Wipro collaborates with companies to bring their practical requirements in an efficient and cost effective manner for any region or health authority concerned. With the advent of new regulatory requirements, the need of technology is more than ever. Wipro can cater to operational as well as technological requirements related to a particular function and keep the company strategically future ready.
Wipro’s strategy is to align as a team with our clients and work towards their growth. Given its expertise in regulatory services, Wipro works on long term associations as well as fixed project delivery. This includes serving pharma companies at every step from pre-approval to post-approval, starting from dossier creation & submission, to renewals, variations, addressing HA queries, labeling, and pharmacovigilance.
Let’s partner for better patient safety!
Wipro’s services for pharmaceuticals (Innovator/Generics/Biopharma/OTC Drugs) regulatory domain
